Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GUD-FLORA: Vaginal Probiotic for Recurrent UTIs
NCT07234227Phase 1Withdrawn
- Sponsor
- Duke University
- Start
- Dec 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of lactobacillus crispatus in urinary tract infection (UTI), sponsored by Duke University. Primary endpoint: Relative abundance of Lactobacillus crispatus at 10 weeks. Planned start Dec 2026; status: withdrawn.
02
Drugs
lactobacillus crispatus
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07234227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07234227.